1.
Grasedieck S, Cabantog A, MacPhee L, Im J, Ruess C, Demir B, Sperb N, Rücker FG, Döhner K, Herold T, Pollack JR, Bullinger L, Rouhi A, Kuchenbauer F. The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements. haematol [Internet]. 2021Dec.2 [cited 2022Aug.15];107(8):1758-72. Available from: https://haematologica.org/article/view/haematol.2020.276048